High levels of stromal cell-derived factor-1α predict secondary cardiac events in stable patients with a history of myocardial infarction.

[1]  P. Libby,et al.  Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". , 2016, Journal of the American College of Cardiology.

[2]  Takuya Shimizu,et al.  Sustained myocardial production of stromal cell-derived factor-1α was associated with left ventricular adverse remodeling in patients with myocardial infarction. , 2015, American journal of physiology. Heart and circulatory physiology.

[3]  S. Miura,et al.  Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease. , 2015, Journal of cardiology.

[4]  A. Dart,et al.  Systemic inflammatory response following acute myocardial infarction , 2015, Journal of geriatric cardiology : JGC.

[5]  Y. Hiroi,et al.  1,5-Anhydro-D-glucitol predicts coronary artery disease prevalence and complexity. , 2014, Journal of cardiology.

[6]  C. Specchia,et al.  Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction. , 2013, Cardiovascular research.

[7]  J. Spence.  Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2013 .

[8]  N. Frangogiannis.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[9]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[10]  M. Hristov,et al.  Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. , 2011, Journal of the American College of Cardiology.

[11]  N. Frangogiannis.  The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. , 2011, Journal of the American College of Cardiology.

[12]  J. Obata,et al.  High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. , 2010, Atherosclerosis.

[13]  M. Pittet,et al.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. , 2010, Circulation.

[14]  N. Hagiwara,et al.  CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction , 2010, Proceedings of the National Academy of Sciences.

[15]  P. Altman,et al.  Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. , 2010, The American journal of pathology.

[16]  G. Maurer,et al.  The inflammatory mediator oncostatin M induces stromal derived factor‐1 in human adult cardiac cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  James W. Smyth,et al.  Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction , 2008, Circulation.

[18]  L. Villeneuve,et al.  Antagonism of stromal cell-derived factor-1α reduces infarct size and improves ventricular function after myocardial infarction , 2007, Pflügers Archiv - European Journal of Physiology.

[19]  H. Haider,et al.  Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. , 2007, Journal of molecular and cellular cardiology.

[20]  Kingston H. Tseng,et al.  Standards of Medical Care in Diabetes–2006 , 2006, Diabetes Care.

[21]  H. Sarau,et al.  Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines , 2004, Circulation.

[22]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[23]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[24]  M. Entman,et al.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. , 2004, The American journal of pathology.

[25]  Eric J Topol,et al.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.

[26]  X. Qian,et al.  SDF-1α production is negatively regulated by mouse estrogen enhanced transcript in a mouse thymus epithelial cell line , 2003 .

[27]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.

[28]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[29]  K. Kugiyama,et al.  Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.

[30]  K. Swedberg,et al.  Short- and long-term neurohormonal activation following acute myocardial infarction. , 1993, American heart journal.

[31]  G. Lamas,et al.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[32]  A. Cohen-Solal,et al.  [Ventricular "remodeling" after myocardial infarction]. , 1991, Archives des maladies du coeur et des vaisseaux.

[33]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[34]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[35]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[36]  Yujie Zhou,et al.  Role of stromal cell-derived factor-1 in patients with non-ST elevation acute coronary syndrome. , 2014, International heart journal.

[37]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[38]  X. Qian,et al.  SDF-1alpha production is negatively regulated by mouse estrogen enhanced transcript in a mouse thymus epithelial cell line. , 2003, Cellular immunology.

[39]  ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  G. Lamas,et al.  Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.

[41]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.